Microdosing Peanut Butter: A New Way to Help Kids With Peanut Allergies

For many parents, a peanut allergy diagnosis means constant vigilance, food label scrutiny, and the fear of a severe reaction if their child takes even one accidental bite. But a new study led by researchers at Mount Sinai Kravis Children’s Hospital in New York suggests that for some kids, a simple, gradual exposure to peanut butter could make life a lot safer — and more normal.

A Fresh Approach to Peanut Allergy

The research, funded by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID), focused on children with what’s called high-threshold peanut allergy. These kids can already tolerate about half a peanut before symptoms appear, but they still face significant risks if they eat more. Until now, the only recommendation for these families was total avoidance, which doesn’t help build any tolerance.

According to Dr. Scott Sicherer, director of the Elliot and Roslyn Jaffe Food Allergy Institute at Mount Sinai and lead author of the study, this group of children has been overlooked in previous clinical trials. “Our findings open the gateway to personalized threshold-based treatments of food allergy,” Sicherer said, describing the work as a possible game-changer for allergy management.

Researchers enrolled 73 children between the ages of 4 and 14 who had high-threshold peanut allergies. The participants were divided into two groups. One group continued avoiding peanuts, while the other began a treatment plan involving small amounts of store-bought peanut butter.

The treatment group started with just 1/8 teaspoon of peanut butter each day. Every eight weeks, under medical supervision, the dose was increased, eventually reaching 1 tablespoon daily over an 18-month period.

The results were striking. At the end of the study, all 32 children in the treatment group could eat up to three tablespoons of peanut butter — about 9 grams of peanut protein — without an allergic reaction. In contrast, only three of the 30 children in the avoidance group could tolerate the same amount.

Sustained Benefits Over Time

To see if the benefits would last, children who completed the treatment continued eating at least two tablespoons of peanut butter weekly for four months, followed by an eight-week period with no peanut consumption.

When they were re-tested, 87% of them still tolerated three tablespoons of peanut butter without a reaction. Overall, nearly 70% of the treated children achieved sustained tolerance compared to less than 10% in the avoidance group.

Dr. Julie Wang, a co-senior author of the study, said the treatment was not only effective but also safe. Only one child required an epinephrine injection during a supervised dose increase, and no severe reactions occurred during at-home dosing.

More than 800,000 children in the U.S. are estimated to have high-threshold peanut allergies. This study provides a new option that could reduce fear of severe reactions and allow children to eat more freely. Dr. Sicherer believes the approach could eventually become part of standard care. “My hope is that this study will eventually change practice to help these children and encourage additional research,” he said.

Researchers plan to explore whether the same gradual exposure strategy could work for other food allergies, such as those to tree nuts, eggs, or milk. They also hope to study how long tolerance lasts and whether it can be maintained with less frequent dosing.

For now, experts caution that parents should never try this approach on their own. All allergen exposure therapy must be guided by a qualified physician, as every child’s allergy is different and reactions can be unpredictable.

Still, this study represents a major step forward. For families managing peanut allergies, a future where kids can safely enjoy peanut butter — instead of fearing it — could be closer than ever.